Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI of Ropivacaine Distribution in Interscalene Plexus Block
NCT02175069Phase 4Completed
- Sponsor
- Paracelsus Medical University
- Start
- Dec 2013
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine in Shoulder disorder, sponsored by Paracelsus Medical University. Primary endpoint: Spread of local anesthetics to the epidural space at 10 minutes. Started Dec 2013; status: completed.
02
Drugs
ropivacaine
03
Conditions
Shoulder disorder
Beyond the preview
Go deeper on NCT02175069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175069.